Bristol Myers Squibb Lunch Symposium: Cardiac myosin inhibition in HCM: Translating theory to practice
Tracks
Arrhythmia / EP
Mechanisms and Preclinical Discovery
Clinical / Surgical
Heart Failure
Imaging
Multidisciplinary
Paediatrics / Adult Congenital
Other
EHJ / HLC
ANZET
Friday, August 2, 2024 |
12:35 PM - 1:35 PM |
Riverview Room 5 |
Speaker
Prof John Atherton
Director of Cardiology
Royal Brisbane and Women's Hospital
Cardiac myosin inhibition in HCM: Translating theory to practice
Biography
John Atherton (MBBS, PhD, FRACP, FCSANZ, FHFA) is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH) and Professor, Faculty of Medicine, University of Queensland.
Professor Atherton was one of four non-European official content reviewers for the 2016 European Society of Cardiology Heart Failure Guidelines and is a European Society of Cardiology Heart Failure Association Ambassador. He chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines, sits on the Therapeutic Guidelines Cardiovascular Expert Group and co-authored the first universal definition of heart failure.
Professor Atherton is Data Custodian for the Queensland Cardiac Outcomes Registry (QCOR)- Heart Failure and sits as a Director on the National Cardiac Registry Board. His clinical and research interests include investigating novel methods to detect pre-symptomatic heart disease, heart failure disease management, hypertrophic cardiomyopathy and cardiac genetics.
Dr Antonios Pantazis
The Royal Brompton and Harefield Clnical Group
Cardiac myosin inhibition in HCM: Translating theory to practice
Biography
Dr Pantazis has many years of experience working within the field of cardiomyopathies and is currently working out of Royal Brompton and Harefield Hospitals.
He was first appointed as a consultant cardiologist at the Heart Hospital, University College London Hospitals NHS Foundation Trust (UCLH), in 2007, and then went on to work as a consultant cardiologist at Barts Heart Centre at St Bartholomew’s Hospital, London, in May 2015.
He was the leading cardiologist at UCLH’s neuromuscular complex care centre (NMCCC) in the National Hospital for Neurology and Neurosurgery.
He was also the leading cardiologist for the interventional and surgical programmes for the management of left-ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy.
Dr Elizabeth Paratz
Cardiologist
St Vincent's Institute of Medical Research
Cardiac myosin inhibition in HCM: Translating theory to practice
Biography
Liz is a cardiologist and World Heart Federation Emerging Leader. Her PhD, completed in 2023 at the Baker Heart & Diabetes Institute, focussed on young cardiac arrest and received the Paul Korner PhD Medal. She is the Wilma Beswick Senior Research Fellow at the University of Melbourne, Deputy Medical Director of the East Timor Hearts Fund and a Designated Aviation Cardiologist.